期刊文献+

白细胞、降钙素原联合C-反应蛋白在COPD患者细菌感染中的诊断价值 被引量:2

The Value of WBC, PCT Combined With CRP in Bacterial Infection in COPD Patients
下载PDF
导出
摘要 目的探析联合检测WBC计数、降钙素原及C反应蛋白在慢性阻塞性肺疾病细菌感染中的诊断价值。方法选择我院73例COPD患者作为研究对象,按是否存在细菌感染,将其分为细菌感染组(n=33)和非细菌感染组(n=40),另选同期35例健康体检者为正常对照组,均进行白细胞、降钙素原以及C-反应蛋白检测。结果细菌感染组WBC、PCT、CRP水平高于非细菌感染组和正常对照组,差异具有统计学意义(P<0.05);且非细菌感染组PCT、CRP值高于正常对照组,差异具有统计学意义(P<0.05);在细菌感染组中,WBC、PCT、CRP联合检测的敏感度为93.94%、特异度为90.91%,均优于WBC、PCT、CRP单一检测,差异具有统计学意义(P<0.05)。结论WBC、PCT、CRP联合检测应用于COPD细菌感染中具有较高的临床诊断价值。 Objective To investigate the diagnostic value of WBC,PCTand CRP inbacterial infection in COPD patients. Methods 73 patientswith COPD were divided into infection group (n=33) and non-infection group (n=40), and 35 healthy persons in the same period as control groupwere treated with WBC, PCT and CRP detection. Results The levels of WBC,PCT and CRP in the infected group were higher than non-infected group and control group,the difference was statistically significant (P 〈 0.05); the level of PCT and CRP in the non-infected group was higher than control group, the difference was statistically significant (P 〈 0.05); the sensitivity of combined detection WBC, PCT, CRP was 93.94 %, specifcity of 90.91%, were significantly better than single detection, the difference was statistically significant (P 〈 0.05). Conclusion Combined detectionof WBC,PCT and CRP in COPD bacterial infection has a high clinicaldiagnostic value.
作者 潘华珍
出处 《中国继续医学教育》 2018年第5期72-74,共3页 China Continuing Medical Education
关键词 慢性阻塞性肺疾病 细菌感染 白细胞 降钙素原 C-反应蛋白 COPD bacterial infection WBC CRP PCT
  • 相关文献

参考文献8

二级参考文献87

  • 1单淑香,陈宝元.慢性阻塞性肺疾病流行病学研究进展[J].国外医学(呼吸系统分册),2005,25(6):440-442. 被引量:44
  • 2杨菊红,胡丽华,李一荣,时杰.血常规结果在常见传染病鉴别诊断中的应用[J].检验医学,2006,21(4):386-388. 被引量:9
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 4Sethi S. Pathogenesis and treatment of acute exacerbations of chronic ob- structive pulmonary disease[ J]. Semin Respir Crit Care Med,2005, 26 (2) : 192-203.
  • 5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic anflam- marion, infection and sepsis : clinical utility and limitations [ J ]. Cfit Care Med,2008,36(2) : 941-952.
  • 6Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy[ J]. Expert Rev Anti Infect Ther,2010,8 (5) :575- 587.
  • 7Rutschmann OT, Comuz J, Poletti PA, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pul- monary disease [ J ]. Thorax, 2007,62 ( 2 ) : 121-125.
  • 8Vestbo J, Hurd SS, Agustf AG, et al. Global strategy for the diag- nosis, management, and prevention of chronic obstructive pulmo- nary disease: GOLD executive summary [ J ]. Am J Respir Crit Care Med, 2013,187(4) :347-365.
  • 9Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations [J]. Crit Care Med, 2008,36(3) :941-952.
  • 10Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract nfections in "reallife" : an international, multicenter poststudy survey (ProREAL) [J]. Arch Intern ned, 2012,172(9):715-722.

共引文献135

同被引文献20

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部